Contributors, vii
Foreword, x
Preface, xi
1 Arterial thrombosis: a brief overview, 1
Lina Badimon and Valentin Fuster
2 Aspirin, 12
Carlo Patrono
3 Platelet ADP P2Y12 inhibitors: thienopyridines, 26
Joseph D. Foley III and David J. Moliterno
4 Platelet ADP P2Y12 inhibitors: nonthienopyridines, 47
Joseph D. Foley III and David J. Moliterno
5 Cilostazol and dipyridamole: more than weak inhibition of
platelets, 62
Wolfgang G. Eisert
6 Interrelationship of thrombin and platelets: the protease
activated receptor-1, 71
Matthew E. Wiisanen and David J. Moliterno
7 Glycoprotein IIb/IIIa inhibitors, 87
Marco Valgimigli and Elisa Cangiano
8 Unfractionated heparin and low molecular weight heparin in
ischemic heart disease, 111
Zafar Iqbal, Omar Hasan, and Marc Cohen
9 Pentasaccharide derivatives, 128
Antonio Gutierrez, Pierluigi Tricoci, and John H.P.
Alexander
10 Intravenous direct thrombin inhibitors, 150
Femi Philip and A. Michael Lincoff
11 Vitamin K antagonists, 166
Freek W.A. Verheugt
12 Oral direct thrombin inhibitors and oral factor Xa
inhibitors, 180
Steen Husted and Lars Wallentin
13 Thrombolytic therapy and concomitant antithrombotic
therapies, 189
Peter R. Sinnaeve and Frans J. Van de Werf
14 Antithrombotic therapy in ST-segment elevation myocardial
infarction, 205
Kurt Huber, Raffaele De Caterina, and Steen Dalby
Kristensen
15 Antithrombotic therapy in non?ST-segment elevation
acute coronary syndromes, 213
Georgios J. Vlachojannis, Vijayalakshmi Kunadian, Joseph M.
Sweeny, and Roxana Mehran
16 Antithrombotic strategies in patients undergoing elective
percutaneous coronary intervention, 236
Sunil V. Rao and E. Magnus Ohman
17 Antithrombotic management in patients with prosthetic
valves,
246
Eric G. Butchart and Raffaele De Caterina
18 Stroke: thrombolysis and antithrombotic therapy, 272
L. Creed Pettigrew and Michael R. Dobbs
19 Atrial fibrillation: current and forthcoming antithrombotic
therapies, 285
Raffaele De Caterina and Giulia Renda
20 Venous thromboembolism: pathophysiology, diagnosis, and
prophylaxis, 306
Marco P. Donadini, Walter Ageno, and Alexander G. Turpie
21 Antithrombotic therapy in venous thrombosis and pulmonary
embolism, 317
Marcello Di Nisio and Harry R. Büller
22 Prevention and treatment of venous and arterial thrombosis
in
patients with specific conditions: diabetes, hypercoagulable
states, pregnancy, and renal insufficiency, 327
Meyer Michel Samama, Jacqueline Conard, and Grigoris
Gerotziafas
23 Genetics of the response to antithrombotic drugs and the
need
for monitoring, 357
Jean-Philippe Collet, Gilles Montalescot, and
Jean-Sébastien Hulot
Index, 378
David Moliterno, M.D, co-director of the Gill Heart Institute,
professor of Internal Medicine and division chief of Cardiovascular
Medicine at the University of Lexington, Kentucky. He is also
inaugurated as the American College of Cardiology Governor of the
Kentucky chapter for the years 2007-2010.
He has 189 articles published as listed on PubMed and is the author
of the following books: Therapeutic Strategies in Thrombosis 1E;
900 Questions: An Interventional Cardiology Board Review.
Raffaele De Caterina, MD, Institute of Cardiology, "G. d'Annunzio"
University, Chieti, Italy.
He has 261 articles published as listed on PubMed and is the author
of the following books: Therapeutic Strategies in Thrombosis 1E;
Endothelial Dysfunctions and Vascular Disease.
Steen Dalby Kristensen, Department of Cardiology, Aarhus University
Hospital, Aarhus N, Denmark.
He has 91 articles published as listed on PubMed and is the author
of the following books: Therapeutic Strategies in Thrombosis 1E.
 |
Ask a Question About this Product More... |
|
